{"organizations": ["U.S. Food and Drug Administration", "Medicare & Medicaid Services", "Bayer", "Harvard Heart Letter", "Advance Clinical Trials Conference", "Espanha", "University", "University of Southern California", "Royalty Interest in Lyrica", "Yasmin Birth Control Pills Have", "AGL", "CMS", "Million Wendel Barr Appointed", "CLIA", "Allied Market Research", "IMEX", "EURONEXT", "Royalty Pharma", "Covance", "ASV", "University of Louisville Grawemeyer Award", "USC", "Galenica Royalty Pharma", "Health Management Systems, Inc.", "Northwestern University", "CTO", "Sanofi"], "uuid": "9667ec4a355d2e1a462a4bf31b80dff56c474041", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/Rigel-and-Aclaris-Therapeutics-International-Sign-License-Agreement-for-JAK-Inhibitors-to-Treat-Skin-Disorders-48146-1/", "country": "US", "title": "Rigel and Aclaris Therapeutics International Sign License Agreement for JAK Inhibitors to Treat Skin Disorders", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "Rigel and Aclaris Therapeutics International Sign License Agreement for JAK Inhibitors to Treat Skin Disorders", "spam_score": 0.0, "site_type": "news", "published": "2015-09-09T15:50:00.000+03:00", "replies_count": 0, "uuid": "9667ec4a355d2e1a462a4bf31b80dff56c474041"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/Rigel-and-Aclaris-Therapeutics-International-Sign-License-Agreement-for-JAK-Inhibitors-to-Treat-Skin-Disorders-48146-1/", "ord_in_thread": 0, "title": "Rigel and Aclaris Therapeutics International Sign License Agreement for JAK Inhibitors to Treat Skin Disorders", "locations": ["United States", "California", "Portugal", "Labs North America", "Aspreva", "Boston", "MA"], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": ["Walter", "Joe Herring", "Yasmin", "Yaz", "Edward Zigler", "Lehmann", "Wendel Barr", "Julie E. Lang", "Barr", "Rigel", "David Turner", "Norris"], "text": " 9/9/2015)... 2015 According to a ... Specialty Enzymes for Pharmaceuticals, Biotechnology R&D and Diagnostics ... specialty enzymes market is expected to register a ... segment accounted for about half of the overall ... Pacific market would exhibit the highest   9, 2015 ANGLE plc (AIM: AGL and ... announce that the University of Southern California (USC) Norris ... from the first phase of its work with ANGLE,s ... Dr Julie E. Lang , ... cancer and notably in molecular profiling of circulating tumor   setembro de 2015 Strathspey Crown Holdings ... em estilos de vida saudável e a IMEX ... consumíveis médicos especializados em Espanha e ... acordo definitivo para que a Strathspey Crown adquira ... filiais e empresas associadas por uma quantia não ... [ 0 ] Global Specialty Enzymes Market is Expected to Reach $947.5 Million, by 2020 - Allied Market Research [ 0 ] Breast Cancer Liquid Biopsy Results Presented At World CDx Conference In Boston [ 0 ] Strathspey Crown adquire o distribuidor oftalmológico IMEX em Espanha e Portugal ... the vaccines division of the sanofi-aventis Group (EURONEXT: SAN ... the U.S. Food and Drug Administration (FDA) has granted ... vaccine, Menactra® (Meningococcal [Groups A, C, Y and W-135] ... schedule for infants and children 9 months through 23 ... ... The following release is being issued by law firms ... & Pinto: According to two new studies ... Journal, Bayer,s birth control pills Yaz and Yasmin, containing ... the risk of serious blood clots (known as venous ... Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants Two New Studies in the British Medical Journal Find That Bayer's Yaz and Yasmin Birth Control Pills Have an Increased Risk of Blood Clot (Date:9/9/2015)... ... ... California based myoscience, inc., continues to revolutionize cryotherapy pain treatments with the release ... consists of a single cannula that is 55mm in length, enabling physicians to reach ... released for the treatment of peripheral nerves to block pain with the iovera° device.   ,   ... management solutions, was chosen as one of only five companies to participate in ... Conference in Boston, MA. Its President, CTO, and Founder, David Turner ,     Nearly half ... is the unmatched love and devotion dogs can offer. But canine companionship may also ... , “Research shows that people who have a dog are far more likely   Nordic Naturals, the ... omega-3 oil. This ultra-concentrated EPA+DHA oil in the highly absorbable, triglyceride form is ... oil unique is the combination of very high concentration and superior absorption,” said     The time ... late 20th century, a group of talented people from around the world collaborate in ... novel \"The Terrability\" tells their dramatic story. , The base must ... [ 0 ] Myoscience Expands Platform Technology for Pain Treatments to Reach Deep Peripheral Nerves [ 0 ] Parallel 6 President, CTO and Founder, David Turner, to Pitch Clinical Reach in DPharm Idol at Disruptive Innovations to Advance Clinical Trials Conference [ 0 ] How a Canine Companion Can Help the Heart, From the September 2015 Harvard Heart Letter [ 0 ] Nordic Naturals® Unveils Next Generation Fish Oil [ 0 ] New Techno Thriller Asks: Can Earth Be Saved From Environmental Disaster? ... (NASDAQ: ASPV ; TSX: ASV) today announced ... final order approving the plan of,arrangement under which ... will acquire all of Aspreva,s outstanding shares at ... The transaction, which is being carried out by ... ... Royalty Pharma and Northwestern,University announced today that ... interest in Lyrica(R) to Royalty Pharma for $700 ... A portion of the payment to Northwestern ... the chemical compound that serves as the basis ... ... Lehmann Named President, Labs North America -, ... today announced that Wendel Barr has been named ... Barr, who is currently,President of Early Development North ... worldwide and will report to,Joe Herring, Covance,s Chairman ... ... Health Management Systems, Inc. (HMS),announced today that it has ... Medicare & Medicaid Services (CMS) under the Medicaid Integrity,Program. ... Orders issued,by CMS for a variety of auditing functions ... is one year; CMS has the,option to renew the ... ... age three and older in the United States would ... won the 2008 University of Louisville Grawemeyer Award in ... the nations young children, fill a gap for working ... and boost the economy, award winners Edward Zigler, Walter ... ... a combination of inexpensive infection control measures, hospitals around the ... resistant tuberculosis (XDR TB), according to a new study in ... Dubbed Ebola With Wings for its ability to spread and ... and has been identified in all regions of the world, ... Aspreva receives final court approval for acquisition by Galenica Royalty Pharma Acquires a Portion of Northwestern University's Royalty Interest in Lyrica(R) for $700 Million Wendel Barr Appointed Chief Operating Officer of Covance CMS Awards Medicaid Integrity Program Contract to HMS 'Preschool for all' would help nation, say 2008 Grawemeyer Award winners Simple strategy could prevent half of deadly tuberculosis infections The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran... ... The BreatheX is a wearable CPAP ... treatment of sleep apnea. The lightweight BreatheX ... of therapy with its built-in, rechargeable battery, ... users will no longer need to be ... Shandon Paraffin Block Cartons...", "external_links": [], "published": "2015-09-09T15:50:00.000+03:00", "crawled": "2015-09-09T16:43:48.380+03:00", "highlightTitle": ""}